Dianthus Therapeutics Inc
NASDAQ:DNTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dianthus Therapeutics Inc
NASDAQ:DNTH
|
US |
|
V
|
Vontobel Holding AG
XBER:VTLN
|
CH |
|
P
|
PSI Software SE
XMUN:PSAN
|
DE |
|
K
|
Kap Industrial Holdings Ltd
JSE:KAP
|
ZA |
|
Gaumont SA
PAR:GAM
|
FR |
|
Central Puerto SA
F:C3TA
|
AR |
|
S
|
Sbf AG
F:CY1K
|
DE |
|
Osmozis SA
PAR:ALOSM
|
FR |
|
Ossur hf
OTC:OSSUY
|
IS |
|
Pharnext SA
PAR:ALPHA
|
FR |
|
O
|
One Enterprise PCL
SET:ONEE
|
TH |
|
Assure Holdings Corp
OTC:IONM
|
US |
|
Hands Form Holdings Ltd
HKEX:1920
|
HK |
|
E
|
Estee Lauder Companies Inc
DUS:ELAA
|
US |
|
B
|
Brunswick Corp
F:BWI
|
US |
|
Asuransi Dayin Mitra Tbk PT
IDX:ASDM
|
ID |
|
Societe Pour l Informatique Industrielle SA
PAR:SII
|
FR |
|
Envestnet Inc
NYSE:ENV
|
US |
|
I
|
IBF Financial Holdings Co Ltd
TWSE:2889
|
TW |
|
Credit Suisse Group AG
SIX:CSGN
|
CH |
|
D
|
Daewonsanup
KOSDAQ:005710
|
KR |
|
Eight Capital Partners PLC
F:ECS0
|
UK |
Wall St Price Targets
DNTH Price Targets Summary
Dianthus Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
DNTH is 142.144 USD with a low forecast of 123.22 USD and a high forecast of 210 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DNTH's stock price target?
Price Target
142.144
USD
According to Wall Street analysts, the average 1-year price target for
DNTH is 142.144 USD with a low forecast of 123.22 USD and a high forecast of 210 USD.
What is the Revenue forecast for Dianthus Therapeutics Inc?
Projected CAGR
143%
The compound annual growth rate for Revenue over the next 8 years is 143%.